<DOC>
	<DOCNO>NCT01291875</DOCNO>
	<brief_summary>The study correlate periodontal disease ( PD ) diabetes mellitus ( DM ) suggest individual poor glycemic control increase risk develop infection . Despite controlled important risk factor , diabetic patient three time likely develop PD , therefore , periodontitis propose sixth complication DM . Besides effect diabetes DP , reverse also study past 15 year , idea chronic acute infection directly affect tissue resistance insulin . Recent study provide evidence control periodontal infection impact improvement glycemic control diabetes mellitus patient . The vascularity inflame periodontal tissue serve gateway inflammatory mediator , pathogenic bacteria product bloodstream . Some researcher suggest periodontal treatment type 2 diabetes mellitus ( DMT2 ) patient , result beneficial effect level glycemic control . However , conclusive evidence support hypothesis . This research project aim determinate impact periodontal therapy metabolic control DMT2 individual , determinate possible association periodontal disease DMT2 . For HbA1c outcome clinical trial sample size calculation estimate 120 patient . For inflammatory serum marker study sample size estimate 22 individual . Blood sample collect evaluation Hba1c inflammatory serum marker . This data highlight possible role periodontal therapy DMT2 metabolic control .</brief_summary>
	<brief_title>Periodontal Treatment Metabolic Control Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<criteria>Subject age 30 year old Subject diagnose T2DM Subject consent study Subject sign severe periodontitis ( least 50 periodontal pocket , PPD &gt; 4mm Bleeding Probing ) Pregnancy Lactation Subject chronic treatment ( i.e. , two week ) specific medication know affect periodontal status ( phenytoin cyclosporine ) within one month baseline visit Subject know HIV Hepatitis ( B , C ) Subjects uncontrolled systemic disease ( cardiovascular disease include hypertension , liver , pulmonary disease , end stage renal failure ) and/or neoplasm Subjects capable provide inform consent Subjects chronic antibiotic therapy require antibiotic coverage periodontal procedure</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Type 2 Diabetes mellitus</keyword>
	<keyword>Periodontal Disease</keyword>
	<keyword>metabolic control</keyword>
	<keyword>periodontal treatment</keyword>
	<keyword>inflammatory marker</keyword>
</DOC>